Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ovarian Neoplasms

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    October 2022
  1. O'ROURKE K
    First person profile: Robert C. Bast Jr MD: As an ovarian cancer expert, Dr Bast has made history by identifying cancer antigen 125, and he has shared his knowledge by mentoring the next generation of physicians: As an ovarian cancer expert, Dr Bast h
    Cancer. 2022;128:3431-3432.
    PubMed    


    June 2022
  2. MARTH C, Abreu MH, Andersen KK, Aro KM, et al
    Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
    Cancer. 2022 Jun 17. doi: 10.1002/cncr.34350.
    PubMed     Abstract available


    January 2022
  3. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available


    December 2021
  4. MCBRIDE CM, Pathak S, Johnson CE, Alberg AJ, et al
    Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.
    Cancer. 2021 Dec 9. doi: 10.1002/cncr.34053.
    PubMed     Abstract available


  5. MOMTAZ P, O'Connor CA, Chou JF, Capanu M, et al
    Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
    Cancer. 2021;127:4393-4402.
    PubMed     Abstract available


    November 2021
  6. TEMKIN SM, Smeltzer MP, Dawkins MD, Boehmer LM, et al
    Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations.
    Cancer. 2021 Nov 17. doi: 10.1002/cncr.34023.
    PubMed     Abstract available


    October 2021
  7. NIERENGARTEN MB
    Rucaparib is a safe and effective maintenance therapy for advanced pancreatic cancer.
    Cancer. 2021;127:3498.
    PubMed    


    September 2021
  8. KOTSOPOULOS J, Kim SJ, Armel S, Bordeleau L, et al
    An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
    Cancer. 2021;127:3183-3193.
    PubMed     Abstract available


    August 2021
  9. HUEPENBECKER SP, Sun CC, Fu S, Zhao H, et al
    Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
    Cancer. 2021 Aug 4. doi: 10.1002/cncr.33829.
    PubMed     Abstract available


    June 2021
  10. MAKHNOON S, Tran G, Levin B, Mattie KD, et al
    Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33668.
    PubMed     Abstract available


    May 2021
  11. KIM SR, Tone A, Kim RH, Cesari M, et al
    Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
    Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
    PubMed     Abstract available


    March 2021
  12. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
    Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
    PubMed     Abstract available


    February 2021
  13. MULLINS MA, Ruterbusch JJ, Clarke P, Uppal S, et al
    Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33488.
    PubMed     Abstract available


  14. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed     Abstract available


  15. SIMON MS, Hastert TA, Barac A, Banack HR, et al
    Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
    Cancer. 2021;127:598-608.
    PubMed     Abstract available


    December 2020
  16. PRINTZ C
    Screening entire populations for breast and ovarian cancer could prevent millions of cases worldwide, study says.
    Cancer. 2020;126:5007.
    PubMed    


    July 2020
  17. LUTGENDORF SK, Penedo F, Goodheart MJ, Dahmoush L, et al
    Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
    Cancer. 2020 Jul 21. doi: 10.1002/cncr.33060.
    PubMed     Abstract available


    May 2020
  18. POORT H, de Rooij BH, Uno H, Weng S, et al
    Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study.
    Cancer. 2020 May 21. doi: 10.1002/cncr.32927.
    PubMed     Abstract available


    April 2020

  19. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.
    Cancer. 2020 Apr 13. doi: 10.1002/cncr.32867.
    PubMed     Abstract available


    March 2020
  20. RUSSO M, Newell JM, Budurlean L, Houser KR, et al
    Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
    Cancer. 2020 Mar 18. doi: 10.1002/cncr.32822.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: